Providing Enhanced Medical Support for Patients with Primary Immunodeficiency Disorders (PIDD): A Patient-Guided Intervention to Ensure Patient Engagement During a Global Pandemic and Beyond
In 2021, the American Academy of Allergy, Asthma and Immunology (AAAAI), the AXDEV Group, and the Immune Deficiency Foundation (IDF) conducted a survey of over 300 PIDD patients. The purpose of this survey was to identify, from a patient perspective, the…
